On April 8th Congress was informed by the the Department of Defense [DoD] that because of emerging threats JBAIDS hemorrhagic fever assays have been deployed to National Guard units of all 50 States.
. “By partnering with the U.S. Army Medical Research and Materiel Command and the Food and Drug Administration, we have made accessible additional diagnostic assays for high
consequence, low probability biological threat agents for use during declared public
health emergencies. This collaboration has facilitated the availability of viral hemorrhagic fever diagnostic assays for use during a declared emergency and adds
previously unavailable preparedness capabilities to this fielded system…
Please follow SGT Report on Twitter & help share the message.